EAC Meeting Program

Jointly Provided by the American College of Allergy, Asthma & Immunology (ACAAI)
and the Eastern Allergy Conference (EAC) 

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology and the Eastern Allergy Conference.  The American College of Allergy, Asthma and Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of tba AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for tba contact hours. 

This activity is supported by educational grants from commercial interests. Complete information will be provided to participants prior to the activity.

In compliance with the Americans with Disabilities Act, EAC requests that any participant in need of accommodations submit a written request to EAC well in advance.  

Please contact Ginny Loiselle at 401-223-1309 or GinnyLoiselle@easternallergyconference.org. 

Thursday

4:00 – 4:30  How important is proper dosing in SCIT and SLIT?

    Harold Nelson, MD

4:30 – 5:00  Current and emerging therapies for EoE

     Ellen Sher, MD

5:00 – 5:15   Q & A

5:15 – 5:45  Signaling pathways in the pathophysiology of atopic dermatitis 

     Mark Boguniewicz, MD

5:45 – 6:15  Managing the difficult MCAS patient

     Anne Maitland, MD

6:15 – 6:30  Q & A

Friday

7:45 – 8:15   Current and emerging therapies for atopic dermatitis

     Mark Boguniewicz, MD

8:15 – 8:20 Q & A

8:20 – 9:30  PBL: Patient with asthma and nasal polyps

     Don Bukstein, MD, Ray Davis, MD, Russell Settipane, MD, Dana Wallace, MD and 

     Richard Wasserman, MD

9:30 – 10:15  Coffee Break, visit exhibits

10:15 – 10:30 PBL case summary

     David Lang, MD

10:30 – 11:00  2020 NHLBI asthma guidelines: What’s new and what’s missing?

     David Lang, MD

11:00 – 11:30 Clinical implications of asthma endotypes and phenotypes

     Dennis Ledford, MD

11:30 – 11:40 Q & A

11:40 – 12:10  CRScNP update

     Russell Settipane, MD

12:10 – 12:20  Q & A

1:15 – 1:45  Treatment options for chronic sinusitis with nasal polyps

      Dana Wallace, MD 

1:45 – 2:15  Idiopathic Anaphylaxis: Diagnosis and management

     Anne Ellis, MD 

2:15 – 2:30  Q & A

Saturday

7:45 – 8:15   Allergy immunotherapy: Literature update

      Harold Nelson, MD

8:15 – 8:20  Q & A

8:20 – 9:30  PBL: COVID-19

     Don Bukstein, MD, Ray Davis, MD, Dennis Ledford, MD, Russell Settipane, MD and  

     Richard Wasserman, MD

9:30 – 10:15  Coffee Break

10:15 – 10:40 Evaluation and management of adverse reactions to vaccines including  COVID-19

      Aleena Banerji, MD

10:40 – 11:05  Immunology: Risk factors and treatment of COVID-19

     Dennis Ledford, MD

11:05 – 11:15  Q & A

11:15 – 11:40  COVID-19: Vaccine misinformation

     Don Bukstein, MD

11:40 – 12:05 COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion vaccine acceptance

      Joseph Bellanti, MD

12:05 – 12:20  Q & A

1:15 – 1:45 Immunoglobulin Replacement for PIDD: Indications for initiating treatment

     Richard Wasserman, MD

1:45 – 2:15  New coding you should have implemented by now

     Gary Gross, MD

2:15 – 2:30  Q & A

Sunday

8:15 – 8:45  Pros and cons of implementing food OIT in a private practice setting

     Richard Wasserman, MD

8:45 – 9:15  Guideline management of HAE: What’s new and what’s missing?

     Christine Radojicic, MD

9:15 – 9:45 β-Lactam antibiotic allergy management

     David Lang, MD 

9:45 – 10:00  Q & A